Sven E. Henningson

Sven E. Henningson is a patent litigation attorney primarily focusing on complex intellectual property disputes, particularly within the pharmaceutical and biotechnology sectors. His practice at Kellogg, Hansen, Todd, Figel & Frederick P.L.L.C. includes intellectual property litigation.

In his tracked appearances, Mr. Henningson has acted as lead counsel exclusively for plaintiffs. His sole tracked case shows him representing the plaintiff, Regeneron Pharmaceuticals, Inc.

A significant aspect of his work includes his role as lead counsel for Regeneron Pharmaceuticals, Inc. in its litigation against Sandoz Inc., part of a broader effort to protect Regeneron's Eylea® product from biosimilar competition. This litigation has involved successful efforts by Regeneron to secure preliminary and permanent injunctions against biosimilar manufacturers, underscoring a strong focus on defending innovator pharmaceutical products.

Information regarding Sven E. Henningson's specific experience in PTAB or IPR proceedings, as well as his bar admissions and educational background, was not readily available through public web searches.